Evidence map›Paper›PMID 39071624›Full record

ArticleHeliyon2024

Zebrafish as a model organism for virus disease research: Current status and future directions.

Sofyantoro Fajar, Sendi Priyono Dwi, Indah Septriani Nur, Aristyaning Putri Wahyu, Mamada Sukamto S, Adipuri Ramadaningrum Winda, Wijayanti Nastiti, Frediansyah Andri, Nainu Firzan

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Recovery of infectious recombinant human norovirus using zebrafish embryos.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Is Zebrafish a Good Model for the Alpha-Gal Syndrome?FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  7. Article
  8. Review
  9. Zebrafish (International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sofyantoro FajarFaculty of Biology, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Sendi Priyono DwiFaculty of Biology, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Indah Septriani NurFaculty of Biology, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Aristyaning Putri WahyuFaculty of Biology, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Mamada Sukamto SDepartment of Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia.
Adipuri Ramadaningrum WindaNational Agency of Drug and Food Control (BPOM), Jakarta, 10560, Indonesia.
Wijayanti NastitiFaculty of Biology, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Frediansyah AndriResearch Center for Food Technology and Processing (PRTPP), National Research and Innovation Agency (BRIN), Yogyakarta 55861, Indonesia.
Nainu FirzanDepartment of Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar, 90245, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zebrafish (

Identifiers

PMID39071624
PMCPMC11282986

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.